Trial Profile

A Phase IIb Clinical Study to Evaluate SB012 in Patients with Ulcerative Colitis

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 22 Mar 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Mar 2019 According to a sterna biologicals media release, the company held a Scientific Advisory Board (SAB) meeting in which particularly the design of the phase IIb study was discussed and further solidified which company is incorporating into the trial protocol in preparation for meetings with regulatory authorities which are expected to hold later this year.
22 Jan 2019 New trial record
07 Jan 2019 According to a sterna biologicals media release, the company has entered into a development agreement with a leading oral formulation company.Under this agreement, sterna and its partner are currently developing an oral formulation prototype. This version will then undergo feasibility testing and optimization for use in clinical trials and final commercial product configuration.Final formulation for phase II is expected in H2 2019.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com